Porth's Essentials of Pathophysiology, 4e - page 295

276 U N I T 3 Hematopoietic Function
R E F E R E N C E S
1. Hall JE. Guyton and Hall Textbook of Medical Physiology. 12th
ed. Philadelphia, PA: Elsevier Saunders; 2011:451–461.
2. Ross MH, Kaye G, Pawlina W. Histology: A Text and Atlas.
6th ed. Philadelphia, PA: Wolters Kluwer Health | Lippincott
Williams & Wilkins; 2011:269–289, 271–272.
3. Kumar V, Abbas AK, Fausto N, et al. Robbins and Cotran
Pathologic Basis of Disease. 8th ed. Philadelphia, PA: Saunders
Elsevier; 2010:115–125, 666–675.
4. Valdez R, Zutter M, Flores AD, et al. Hematopathology. In:
Rubin R, Strayer DS, eds. Rubin’s Pathology: Clinicopathologic
Foundations of Medicine . 6th ed. Philadelphia, PA: Wolters
Kluwer Health | Lippincott Williams & Wilkins; 2012:947–998.
5. Weitz JI. Overview of hemostasis and thrombosis. In: Huffman
R, Benz EJ Jr, Silverstein LE, et al. Hoffman Hematology: Basic
Principles and Practice. 4th ed. London, UK: Elsevier Churchill
Livingstone; 2013:1774–1783.
6. Messmore HL, Jeske WP, Wehrmacher W, et al. Antiplatelet
agents: current drugs and future trends. Hematol Oncol Clin
North Am. 2005;19:87–117.
7. Zehnder JL. Drugs used in disorders of coagulation. In: Katzung
BG, ed. Basic and Clinical Pharmacology . 12th ed. New York,
NY: McGraw-Hill; 2012:601–618.
8. Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J
Med. 2008;359(9):938–949.
9. Schafer AI. Thrombocytosis. N Engl J Med.
2004;350:1211–1219.
10. Bloomenthal D, von Dadelszen P, Liston R, et al. The effect of
factor V Leiden carriage on maternal and fetal health. Can Med
Assoc J. 2002;167:48–54.
11. Chrousos GP. The gonadal hormones and inhibitors. In: Katzung
BG, ed. Basic and Clinical Pharmacology . 12th ed. New York,
NY: McGraw-Hill; 2011;715–739.
12. Levine JS, Branch DW, Rausch J. The antiphospholipid
syndrome. N Engl J Med. 2002;346:752–763.
13. Hanly JC. Antiphospholipid syndrome: an overview. Can Med
Assoc J. 2003;168:1675–1682.
14. Lin W, Crowther MA, Eikelboom JW. Management
of antiphospholipid antibody syndrome. JAMA.
2006;295:1050–1057.
15. Nachman RL, Rafii S. Platelets, petechiae, and preservation of
the vascular wall. N Engl J Med. 2008;359(12):1261–1270.
16. Bromberg ME. Immune thrombocytopenia purpura: the
changing therapeutic landscape. N Engl J Med. 2006;355:
1643–1645.
17. Cines DB, Blanchette VS. Immune thrombocytopenic purpura.
N Engl J Med. 2002;346:995–1008.
18. van den Bemt PM, Meyboom RH, Egberts AC. Drug-induced
immune thrombocytopenia. Drug Saf. 2004;27:1243–1252.
19. Franchini M. Heparin-induced thrombocytopenia: an update.
Thromb J. 2005;3:14–18.
20. Mannucci PM, Tuddenham EGD. The hemophilias: from royal
genes to gene therapy. N Engl J Med. 2001;344:1773–1779.
21. Carcoa M, Moorehead P, Lillicrap D. Hemophilia A and B.
In: Huffman R, Benz EJ Jr, Silverstein LE, et al., eds. Hoffman
Hematology: Basic Principles and Practice . 4th ed. London, UK:
Elsevier Churchill Livingstone; 2013:1940–1960.
22. Lillicrap D. Von Willebrand disease: advances in
pathogenetic understanding, diagnosis, and therapy. Blood.
2013;122:3735–3740.
23. Mannucci PM. Treatment of von Willebrand’s disease. N Engl J
Med. 2004;351:683–694.
24. Soliman DE, Broadman LM. Coagulation defects. Anesthesiol
Clin. 2006;24:549–578.
25. Sadler JV. New concepts in von Willebrand disease. Annu Rev
Med. 2005;56:173–180.
26. Klinge J, Ananyeva NM, Hauser C, et al. Hemophilia A: from
basic science to clinical practice. Semin Thromb Hemost.
2002;28:309–322.
27. Mannucci PM. Desmopressin (DDAVP) in the treatment
of bleeding disorders: the first 20 years. Blood.
1997;90:2515–2521.
28. Kitchens CS. Thrombocytopenia and thrombosis in disseminated
intravascular coagulation (DIC). Hematology. 2009:240–246.
29. Franchini M, Lippi G, Manzato F. Recent acquisitions in the
pathophysiology, diagnosis and treatment of disseminated
intravascular coagulation. Thromb J. 2006;4:4–12.
30. Van der Poll T, Jonge E, Levi M. Regulatory role of cytokines in
disseminated intravascular coagulation. Semin Thromb Hemost.
2001;27:639–651.
31. Levi M. Disseminated intravascular coagulation. Crit Care Med.
2007;35(9):2191–2195.
Porth Essentials Resources
Explore these additional resources to enhance learning
for this chapter:
• NCLEX-Style Questions and Other Resources
on ,http://thePoint.lww.com/PorthEssentials4e
• Study Guide for Essentials of Pathophysiology
• Concepts in Action Animations
• Adaptive Learning | Powered by PrepU,http://thepoint.lww.com/
prepu